share_log

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26

Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $26

Canaccord Genuity維持對Privia Health Gr的買入,將目標股價下調至26美元
Benzinga ·  05/10 14:46

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $37 to $26.

Canaccord Genuity分析師理查德·克洛斯維持Privia Health Gr(納斯達克股票代碼:PRVA)的買入並將目標股價從37美元下調至26美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論